Union Cabinet on Thursday (10 January) approved establishment of three new All India Institute of Medical Science (AIIMS) - two in Jammu and Kashmir (J&K) and one in Gujarat - under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) scheme.
The two AIIMS in Jammu and Kashmir will be set up at Vijaynagar in Jammu and Awantipura in Kashmir with an estimated cost of Rs 1,661 crore and Rs 1,828 crore respectively. AIIMS in Gujarat will be setup in Rajkot at a cost of Rs 1,195 crore, The New Indian Express has reported.
“Establishment of new AIIMS involves creation of hospital, teaching block for medical and nursing courses, residential complex and allied facilities/services, broadly on the pattern of AIIMS, New Delhi and other six new AIIMS taken up under Phase-I of PMSSY,” an official release said.
Each new AIIMS will add 100 UG (MBBS) seats and 60 BSc (Nursing) seats, and have 15-20 super specialty departments. The three institutes will each add around 750 hospital beds including emergency beds, Ayush beds, private beds and ICU speciality and super speciality beds.
“It is expected that each new AIIMS would cater to around 1,500 OPD patients per day and around 1,000 IPD patients per month. There will be a medical college, Ayush Block, Auditorium, Night Shelter, Guest House, Hostels and residential facilities,” added the statement.
Prime Minister, in 2015, had announced the setting up of two new AIIMS in Jammu and Kashmir while announcement about the one in Gujarat was done by Finance Minister in his 2017-18 budget speech.
As you are no doubt aware, Swarajya is, all in all, a reader-subscription-backed business model and in order to make sure we build a media platform with only the best interests of India at heart, we need your backing.
And in challenging times like this, we need your support now more than ever—to continue bringing you stories that are often shrugged off.
For us to invest in quality reporting and continue bringing you the right stories, it takes a lot of time and money.
Partner with us, be a patron or a subscriber. We need your support, throughout.